Vital Therapies reported $113.68M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Biomarin Pharmaceutical BMRN:US USD 4.6B 34.64M
Dynavax Technologies DVAX:US USD 581.01M 80.44M
Enanta Pharmaceuticals ENTA:US USD 300.84M 20.5M
Insmed INSM:US USD 87.95M 117.91M
Intercept Pharmaceuticals ICPT:US USD 93.08M 14.6M
Mirati Therapeutics MRTX:US USD 996.52M 132.54M
Omeros OMER:US USD 85.68M 132M
Orasure Technologies OSUR:US USD 363.62M 21.73M
Quidel QDEL:US USD 4.93B 139.3M
Regulus Therapeutics RGLS:US USD 39.67M 2.7M
Revance Therapeutics RVNC:US USD 12.6M 133.11M
Ultragenyx Pharmaceutical RARE:US USD 352.49M 116.34M
United Therapeutics UTHR:US USD 4.8B 234.5M
Vital Therapies VTL:US USD 113.68M 4.87M